Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Gains from Investment Securities (2023 - 2025)

Fractyl Health (GUTS) has disclosed Gains from Investment Securities for 3 consecutive years, with $2.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities rose 204.73% year-over-year to $2.4 million, compared with a TTM value of $2.4 million through Sep 2025, down 49.43%, and an annual FY2024 reading of -$17.9 million, down 363.59% over the prior year.
  • Gains from Investment Securities was $2.4 million for Q3 2025 at Fractyl Health, up from $348000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $11.9 million in Q2 2024 and bottomed at -$17.9 million in Q4 2024.
  • Average Gains from Investment Securities over 3 years is -$648774.8, with a median of $348000.0 recorded in 2025.
  • Peak annual rise in Gains from Investment Securities hit 9089.92% in 2024, while the deepest fall reached 522400.0% in 2024.
  • Year by year, Gains from Investment Securities stood at $5.6 million in 2023, then plummeted by 417.89% to -$17.9 million in 2024, then skyrocketed by 113.41% to $2.4 million in 2025.
  • Business Quant data shows Gains from Investment Securities for GUTS at $2.4 million in Q3 2025, $348000.0 in Q2 2025, and $2.1 million in Q1 2025.